The Aging Population Drives Growth In Colorectal Cancer Screening Demand: A Significant Driver Propelling The Colorectal Cancer Screening Market In 2025

The Colorectal Cancer Screening Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Colorectal Cancer Screening Market Size and Projected Growth Rate?
The colorectal cancer screening market has expanded significantly. It is expected to rise from $15.61 billion in 2024 to $16.6 billion in 2025 at a CAGR of 6.3%. Key drivers of historical growth include the increasing incidence of colorectal cancer, rising government awareness campaigns, an aging population, growing adoption of colonoscopy, and improved insurance coverage for screenings.

The colorectal cancer screening market is projected to grow significantly, reaching $21.01 billion by 2029 at a CAGR of 6.1%. Growth drivers include the increasing adoption of non-invasive screening methods, a rise in home-based testing, the growing prevalence of obesity, the shift towards value-based TH*Care, and increasing collaborations between public and private sectors. Key trends in this market include the integration of AI in screening and diagnostics, the expansion of screening guidelines to younger populations, broader use of genomic testing for cancer risk assessment, the growth of mobile health (mHealth) platforms, and partnerships between pharmaceutical and diagnostic companies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19008

What Are the Major Segments in the Colorectal Cancer Screening Market?
The colorectal cancer screeningmarket covered in this report is segmented -

1) By Type: Stool-Based, Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), Stool Deoxyribonucleic Acid (DNA) Test, Colonoscopy, Other Types
2) By Age Group: Below 50 Years, 50-64 Years, Above 65 Years
3) By End User: Hospitals And Clinics, Clinical Laboratories, Diagnostic Imaging Centers, Other End-Users

Subsegments:
1) By Stool-Based Tests: Stool-Based Tests
2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT, Low-Sensitivity FIT
3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT, Immunochemical FOBT
4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test, Single-Target Stool DNA Test
5) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy
6) By Other Types: Virtual Colonoscopy, Flexible Sigmoidoscopy, Capsule Endoscopy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19008&type=smp

What Are The Driving Colorectal Cancer Screening Market Evolution?
The aging population is expected to drive the growth of the colorectal cancer screening market. As the proportion of older adults continues to rise globally, the risk of colorectal cancer increases, making regular screening crucial for early detection and prevention. With more individuals aged 65 and older, especially in the U.S., the demand for colorectal cancer screening is expected to grow significantly in the coming years.

Which Firms Dominate The Colorectal Cancer Screening Market Segments?
Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE TH*Care, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

What Trends Are Driving Growth in The Colorectal Cancer Screening Market?
In the colorectal cancer screening market, innovative solutions like non-invasive multi-target stool RNA screening tests are being developed to detect colorectal cancer early. For example, in May 2024, Geneoscopy Inc. received FDA approval for ColoSense, a stool-based test that analyzes RNA biomarkers to detect colorectal cancer and precancerous lesions. This test demonstrated high sensitivity, particularly in younger populations, and aims to increase screening participation by offering a less invasive alternative to traditional methods.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-screening-global-market-report

Which Is The Largest Region In The Colorectal Cancer Screening Market?
North America was the largest region in the colorectal cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Colorectal Cancer Screening Market?
2. What is the CAGR expected in the Colorectal Cancer Screening Market?
3. What Are the Key Innovations Transforming the Colorectal Cancer Screening Industry?
4. Which Region Is Leading the Colorectal Cancer Screening Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.